| First Author | Jabara HH | Year | 2009 |
| Journal | Int Immunol | Volume | 21 |
| Issue | 4 | Pages | 477-88 |
| PubMed ID | 19228877 | Mgi Jnum | J:147101 |
| Mgi Id | MGI:3839221 | Doi | 10.1093/intimm/dxp013 |
| Citation | Jabara HH, et al. (2009) TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40. Int Immunol 21(4):477-88 |
| abstractText | The isotype switch defect in CD40(-/-) mice is corrected by wild-type (WT) CD40 transgene, but not by a mutant CD40 transgene that does not bind tumor necrosis factor receptor-associated factors (TRAF) 2 and 3. To define the individual roles of TRAF2 and TRAF3 in CD40 activation of B cells, we introduced mutant CD40 transgenes that selectively lack the ability to bind TRAF2 (DeltaTR2), TRAF3 (DeltaTR3) or both (DeltaTR2,3) into B cells of CD40(-/-) mice. Serum IgG1 and IgE levels, IgG1 antibody response to sub-optimal doses of the T cell-dependent antigen keyhole limpet hemocyanin, germinal center formation, CD40-mediated proliferation, isotype switching and activation of the non-canonical NF-kappaB pathway were partially diminished in DeltaTR2 and DeltaTR3 mice and virtually absent in DeltaTR2,3 mice. These results suggest that TRAF2 and TRAF3 can each independently mediate class switch recombination (CSR) driven by CD40, but both are required for optimal CD40-driven isotype switching. |
